Evaluating the properties of a frailty index and its association with mortality risk among patients with systemic lupus erythematosus.
Safety and efficacy of belimumab plus standard therapy for up to 13 years in patients with systemic lupus erythematosus.
Use of combined hormonal contraceptives among women with systemic lupus erythematosus with and without medical contraindications to oestrogen.
